<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019538</url>
  </required_header>
  <id_info>
    <org_study_id>897</org_study_id>
    <nct_id>NCT01019538</nct_id>
  </id_info>
  <brief_title>Pre-flight Titration of Supplemental Oxygen</brief_title>
  <official_title>COPD and Air Travel: Oxygen Equipment and Pre-flight Titration of Supplemental Oxygen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if supplemental oxygen during air travel can be
      reliably titrated using a Hypoxia-altitude simulation test (HAST). Also, the effect of oxygen
      supplementation given with the various oxygen equipment allowed for air travel is studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      International guidelines recommend supplemental oxygen if PaO2 &lt; 6.7 kPa (50 mmHg) during air
      travel. Hypobaric chamber exposure is the ideal test but is not widely available. In clinical
      practice, the HAST has been recommended as the preferable test for pre-flight evaluation, and
      is used with increasing frequency. The oxygen dose during air travel has been recommended
      titrated during HAST. In the study, supplemental oxygen titration during hypobaric chamber
      exposure is compared to oxygen titration during HAST, to evaluate if HAST can be used with
      confidence to titrate the amount of supplemental oxygen needed during air travel.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>PaO2 obtained from oxygen titration during HAST vs hypobaric chamber</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pre-flight test with supplemental oxygen</intervention_name>
    <description>The Hypoxia-altitude simulation test, which is established in clinical practice, is compared to the gold standard of hypobaric chamber while giving supplemental gaseous oxygen without and with oxygen conserving device, and with oxygen concentrator.</description>
    <other_name>Oxygen</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Arterial blood gases
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients who have performed a Hypoxia-altitude simulation test with a PaO2 &lt; 6.7
             kPa

        Exclusion Criteria:

          -  exacerbation or pneumothorax within the previous six weeks

          -  LTOT

          -  anemia

          -  pulmonary disease other than COPD

          -  cerebrovascular or symptomatic cardiovascular disease

          -  claustrophobia

          -  inability to equalize pressure in the middle ear
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ole H Skjønsberg, Prof.dr.med</last_name>
    <role>Study Director</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aina Akerø, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University Hospital Ullevaal, Department of Pulmonary Medicine</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Gong H Jr, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis. 1984 Dec;130(6):980-6.</citation>
    <PMID>6508019</PMID>
  </reference>
  <reference>
    <citation>Akerø A, Christensen CC, Edvardsen A, Skjønsberg OH. Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J. 2005 Apr;25(4):725-30.</citation>
    <PMID>15802350</PMID>
  </reference>
  <reference>
    <citation>Akerø A, Christensen CC, Edvardsen A, Ryg M, Skjønsberg OH. Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease. Aviat Space Environ Med. 2008 May;79(5):518-24.</citation>
    <PMID>18500050</PMID>
  </reference>
  <reference>
    <citation>Dine CJ, Kreider ME. Hypoxia altitude simulation test. Chest. 2008 Apr;133(4):1002-5. doi: 10.1378/chest.07-1354. Review.</citation>
    <PMID>18398121</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2009</study_first_submitted>
  <study_first_submitted_qc>November 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>July 3, 2011</last_update_submitted>
  <last_update_submitted_qc>July 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ole Henning Skjønsberg, Prof., dr.med</name_title>
    <organization>Oslo University Hospital, Ullevaal, Department of Pulmonary Medicine</organization>
  </responsible_party>
  <keyword>Oxygen</keyword>
  <keyword>Hypoxemia</keyword>
  <keyword>Air travel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

